WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
(RTTNews) - Repligen Corporation (RGEN), a life sciences company, on Monday announced the launch of its CTech SoloVPE PLUS System, an advanced tool for at-line concentration measurement in biological ...
Novasign and Repligen entered into a strategic partnership to develop and integrate Novasign’s machine learning and modeling workflow into Repligen filtration systems. As part of the partnership, ...
One-Time Therapeutics Player Bets Future on Working as Supplier to Bioprocess Companies Repligen, once a strongly focused therapeutics firm, has transformed itself into a bioprocess products company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results